Aker BioMarine ASA – Invitation to presentation of the second quarter 2026 results

Aker BioMarine will release the second quarter 2026 results on Friday 10 July 2026 at 07:00 CET.

At 09:00 CET on the same day, the management will host a webcast to present the results. Following a presentation, there will be a Q&A session where written questions can be submitted to ir@akerbiomarine.com.

A replay of the presentation will be made available soon after the presentation at the same web page.

For further information, please contact Christopher Robin Vinter, SVP Finance Mobile: +47 911 60 820 Email: christopher.vinter@akerbiomarine.com

About Aker BioMarine Aker BioMarine is a leading human health and nutrition innovator that develops krill-derived products for consumer health and nutrition. Krill is a natural, powerful, and health-promoting source of nutrients from the pristine waters of Antarctica, and Aker BioMarine has a unique position in its industry. The ingredient portfolio consists of Superba Krill Oil, Lysoveta, Revervia, and PL+, as well as the consumer brand, Kori Krill. The innovative approach also extends into the spin-offs AION (reduce and recycle plastic waste across industries) and Understory (a protein brand). Aker BioMarine is listed on the Oslo Stock Exchange (AKBM). More information is available at www.akerbiomarine.com.

More information: Access the news on Oslo Bors NewsWeb site